Skip to content

Microdosing psychedelics – Does it have an impact on emodiversity?

Ioana Pop, Jannis Dinkelacker

Journal of Psychedelic Studies January 17, 2023 DOI: 10.1556/2054.2022.00208 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cohort Peer reviewed
Sample size 18
Population Experienced microdosers with an active microdosing practice
Intervention Microdosing
Duration 28 days
Topics Microdosing
Keywords Mood Affect linguistics Test biology Communication
Citations 4
Key findings Microdosing days were associated with lower positive and overall emodiversity, not higher as hypothesized.

Abstract

Abstract Background and aims Previous research has proposed that microdosing, i.e., the repeated use of sub-threshold doses of serotonergic hallucinogens, has an impact on mood by increasing emotional awareness. We propose that increased emotional awareness could translate into higher emodiversity, a balanced experience of emotions in which emotions are experienced with more similarity in intensity and duration. We examine the effect of microdosing, the day after, as well as the cumulative effect of microdosing on overall, positive and negative emodiversity.

Methods: We use data collected over a period of 28 days sampled between February to June 2020 from 18 users that already had an active practice of microdosing at the start of the data collection. We assessed emotional states using ESM methods, i.e., signal-contingent sampling with triggers sent 5 times a day. The working dataset has a number of 224 observations days. We used mixed effects models to test our hypotheses.

Results: When taking into account the level of average affect, we found that during microdosing days positive and overall emodiversity were significantly lower. No evidence was found for a mediating role of the level of average affect. Higher cumulative instances of microdosing were not related to any of the emodiversity indexes. Participants experienced more “awe, wonder, or amazement”, “ashamed, humiliated, or disgraced” as well as less “joyful, glad, or happy” emotions during microdosing days.

Conclusion: A microdosing practice may increase the centrality of certain emotions on microdosing days, resulting in a decrease in emotional diversity.

Comparable studies

Other observational and cohort studies on microdosing, most cited first.

Study Year Design Participants
Microdosing psychedelics: personality, mental health, and creativity differences in microdosers Respondents recruited from online forums 2019 Observational study
Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing Individuals planning a weekly microdosing regimen 2021 Prospective observational study n = 81
Might Microdosing Psychedelics Be Safe and Beneficial? An Initial Exploration. More than a thousand individuals from 59 countries 2019 Observational cohort n = 1,000
Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls Psilocybin microdosers and non-microdosing comparators 2022 Naturalistic observational study n = 1,133
Nonlinear Pharmacokinetics of Oral Quinidine and Verapamil in Healthy Subjects: A Clinical Microdosing Study Healthy subjects 2011 Observational cohort

Citations in the library

Explore topics